References in periodicals archive ?
Based on drug, the dermatology drugs market has been mainly classified into Humira, Remicade, Otezla, Stelara, Enbrel, Cosentyx, Neoral, Taltz, Cubicin, Canesten, Zyvox, Dupixent, Protopic, Valtrex, and Eucrisa.
Growth in these areas was largely offset by the effects of generic and biosimilar competition that resulted in sales declines for products including Zetia, Vytorin, Cubicin and Remicade.
Eighteen (72%) patients were treated with ciprofloxacin (Cipro 400 mg flakon, Biopharma, Istanbul, Turkey), two (8%) patients with ciprofloxacin (Cipro 400 mg flakon, Biopharma, Istanbul, Turkey) and piperacillin tazobactam (Tazocin 4.5 g flakon, Pfizer, New York, USA), two (8%) patients with meropenem (Meronem 1 g flakon, Astra Zeneca, Cambridge, England), two (8%) patients with ciprofloxacin (Cipro 400 mg flakon, Biopharma, Istanbul, Turkey) and daptomycin (Cubicin 500 mg flakon, Novartis, Basel, Switzerland), and one (4%) patient with meropenem (Meronem 1 g flakon, Astra Zeneca, Cambridge, England) and linezolid (Zyvoxid 600 mg flakon, Pfizer, New York, USA).
--Orbactiv (oritavancin) and Cubicin (daptomycin)--spent 17.2 years and
The four drugs are Cubicin, indicated for complex skin infections and bloodstream infections, with sales of $1.17 billion; Vytorin, a cholesterol drug that contributes $1.12 billion; Invanz, used to treat a variety of bacterial infections and generating $544 million in sales; and Cancidas, prescribed for treatment of candidemia and other Candida infections, with annual sales of $540 million.
M2 EQUITYBITES-September 19, 2016-Teva unveils approved generic antibacterial drug Cubicin (Daptomycin for Injection) in the US
M2 PHARMA-September 19, 2016-Teva unveils approved generic antibacterial drug Cubicin (Daptomycin for Injection) in the US
Cubist draws most of its revenue from the antibiotic Cubicin, and it also has developed another treatment, Zerbaxa, that targets complicated urinary tract and intra-abdominal infections.
Cubist's antibiotic CUBICIN, the only approved once-a-day therapy for both S.
While the dosage on most medications will be unaffected by weight, there are a few prescriptions, such as the antibiotic Cubicin, which may require a higher amount.
From January 2003 until July 2004 he served as Senior Vice President, Research and Development, where he helped lead the FDA approval team for CUBICIN. Dr.